Sympathetic ophthalmia following vitrectomy for endophthalmitis after intravitreal bevacizumab

Research output: Contribution to journalArticle

5 Scopus citations


Purpose: To describe a case of sympathetic ophthalmia following vitrectomy for endophthalmitis after an intravitreal injection of bevacizumab. Design: Retrospective case report. Methods: An 84-year-old male developed sympathetic ophthalmia 4 months after vitrectomy for endophthalmitis following an intravitreal injection. The inciting blind eye was enucleated. Results: Histopathology demonstrated sympathetic ophthalmia and phacoanaphylactic endophthalmitis. Visual acuity improved from 20/200 to 20/30 in the sympathizing eye with a combination of oral prednisone and azathioprine. Conclusions: Sympathetic ophthalmia can develop following exogenous endophthalmitis but has a good visual prognosis with appropriate treatment.

Original languageEnglish (US)
Pages (from-to)236-238
Number of pages3
JournalOcular Immunology and Inflammation
Issue number5-6
StatePublished - Sep 1 2008



  • Endophthalmitis
  • Intravitreal bevacizumab
  • Phacoanaphylactic endophthalmitis
  • Sympathetic ophthalmia
  • Vitrectomy

ASJC Scopus subject areas

  • Ophthalmology
  • Immunology and Allergy

Cite this